Agnieszka Kalińska‐Bienias

Measuring of quality of life in autoimmune blistering disorders in Poland. Validation of disease – specific Autoimmune Bullous Disease Quality of Life (ABQOL) and the Treatment Autoimmune Bullous Disease Quality of Life (TABQOL) questionnaires

Agnieszka Kalińska‐Bienias, Beata Jakubowska, Cezary Kowaléwski et al. · Advances in Medical Sciences · 2017 · 37 citations · Full text

Medicine, Immunology, Autoimmunity +13

Terbinafine-induced subacute cutaneous lupus erythematosus in two patients with systemic lupus erythematosus successfully treated with topical corticosteroids

Agnieszka Kalińska‐Bienias, Cezary Kowaléwski, Katarzyna Woźniak · Advances in Dermatology and Allergology · 2013 · 36 citations · Full text

Medicine, Dermatology, Immunology +17

Mortality in bullous pemphigoid and prognostic factors in 1st and 3rd year of follow-up in specialized centre in Poland

Agnieszka Kalińska‐Bienias, Katarzyna Lukowska-Smorawska, Paweł Jagielski et al. · Archives of Dermatological Research · 2017 · 30 citations · Full text

Social Sciences, Health Sciences, Clinical Epidemiology +8

Heart Rate Turbulence Impairment and Ventricular Arrhythmias in Patients with Systemic Sclerosis

Piotr Bienias, Michał Ciurzyński, Maria Glińska-Wielochowska et al. · Pacing and Clinical Electrophysiology · 2010 · 23 citations · Full text

Medicine, Cardiology, Clinical Sciences +14

Tetracycline, nicotinamide, and lesionally administered clobetasol as a therapeutic option to prednisone in patients with bullous pemphigoid: a comparative, retrospective analysis of 106 patients with long‐term follow‐up

Agnieszka Kalińska‐Bienias, Emilia Kowalczyk, Paweł Jagielski et al. · International Journal of Dermatology · 2018 · 20 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15